Brief: Advanced Enzyme Technologies Announces Positive Clinical Breakthrough In Randomized Controlled Trials To Resolve 'Long Covid' Fatigue Symptoms
13/09/2021 06:32
Sept 13 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS :
* ADVANCED ENZYME TECHNOLOGIES - POSITIVE CLINICAL BREAKTHROUGH IN RANDOMIZED CONTROLLED
TRIALS TO
RESOLVE 'LONG COVID' FATIGUE SYMPTOMS
Source text for Eikon: ID:nBSE7WRlR6
Further company coverage: ADEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Advanced Enzyme Technologies
See all newsIndia's Advanced Enzyme jumps most in over four years after quarterly profit rise
Brief: Advanced Enzyme Technologies JC Biotech Approves Collaboration With Raywatt Solar Power
India's Advanced Enzyme falls on Q4 profit drop
Brief: Advanced Enzyme Technologies Says Unit To Form A New Corporation In California, US
India's Advanced Enzyme Technologies up on qtrly-profit rise